J Biomed Nanotechnol. 2019 Sep 1;15(9):1867-1880. doi: 10.1166/jbn.2019.2825.
The present study aims to evaluate the effect of the ethyl acetate extract of (EAEC) as a novel photosensitizer in photodynamic therapy (PDT) of colorectal carcinoma (CRC) HCT116 and SW620 cells. The absorption and fluorescence spectra of EAEC were measured using a UV-vis spectrophotometer and fluorescence spectrophotometer, respectively. EAEC-induced reactive oxygen species (ROS) production in HCT116 and SW620 cells was detected using 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA) and glutathione/glutathione disulfide (GSH/GSSG). The photo- and dark toxicities of EAEC were estimated using the Cell Counting Kit-8 (CCK-8) assay. Cellular uptake and localization of EAEC were detected by confocal laser fluorescence microscopy. Annexin V-FITC/PI staining, Western blotting and immunofluorescence staining were used to assess apoptosis and autophagy. The antitumor activity of EAEC was confirmed in a xenograft model. Finally, effects on the PERK pathway were verified using qRT-PCR and Western blotting. EAEC displayed absorption and fluorescence emission peaks at 660 nm and 678 nm, respectively. EAEC induced ROS production in CRC cells. Assessment of dark toxicity showed that treatment with EAEC alone induced little cytotoxicity in CRC or normal cells but that EAEC-PDT induced significant photocytotoxicity in CRC cells in a time- and dose-dependent manner. After cellular uptake, EAEC was located in the mitochondria. Treatment with EAEC-PDT reduced xenograft tumor size. Further evaluation suggested that activation of the PERK pathway mediates these effects, as the apoptotic rate and autophagy flux increased markedly after EAEC-PDT. EAEC, a natural photosensitizer extracted from , displays potential utility in PDT of CRC by targeting the PERK pathway.
本研究旨在评估从 ()中提取的乙酸乙酯提取物(EAEC)作为一种新型光敏剂在结直肠癌细胞(CRC)HCT116 和 SW620 细胞光动力疗法(PDT)中的作用。采用紫外可见分光光度计和荧光分光光度计分别测定 EAEC 的吸收光谱和荧光光谱。采用 2',7'-二氯二氢荧光素二乙酸酯(DCFH-DA)和谷胱甘肽/谷胱甘肽二硫化物(GSH/GSSG)检测 EAEC 诱导的 HCT116 和 SW620 细胞中活性氧(ROS)的产生。采用细胞计数试剂盒-8(CCK-8)测定法评估 EAEC 的光毒性和暗毒性。通过共聚焦激光荧光显微镜检测 EAEC 的细胞摄取和定位。采用 Annexin V-FITC/PI 染色、Western blot 和免疫荧光染色评估细胞凋亡和自噬。在异种移植模型中证实了 EAEC 的抗肿瘤活性。最后,通过 qRT-PCR 和 Western blot 验证对 PERK 通路的影响。EAEC 在 660nm 和 678nm 处分别显示出吸收和荧光发射峰。EAEC 诱导 CRC 细胞中 ROS 的产生。暗毒性评估表明,单独使用 EAEC 处理 CRC 或正常细胞几乎不会引起细胞毒性,但 EAEC-PDT 以时间和剂量依赖的方式显著诱导 CRC 细胞的光细胞毒性。细胞摄取后,EAEC 位于线粒体中。EAEC-PDT 治疗可减小异种移植肿瘤的大小。进一步评估表明,PERK 通路的激活介导了这些效应,因为 EAEC-PDT 后凋亡率和自噬通量明显增加。从 中提取的天然光敏剂 EAEC 通过靶向 PERK 通路显示出在 CRC PDT 中的潜在应用价值。